BIOMAT Database Logo BIOMAT Database Logo

[Anti-HTLV III/LAV antibodies of the IgM class in subjects at risk with negative anti-HTLV III/LAV IgG ELISA results (preliminary results)]. 1986

G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D008297 Male Males
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D006716 Homosexuality The sexual attraction or relationship between members of the same SEX. Homosexuality, Ego-Dystonic,Ego-Dystonic Homosexuality,Homosexuality, Ego Dystonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
IgM and IgG antibodies to HTLV-III in the lymphadenopathy syndrome and subjects at risk for AIDS.
September 1985, British medical journal (Clinical research ed.),
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
Evaluation of eight ELISA kits for the detection of anti-LAV/HTLV-III antibodies.
May 1986, Lancet (London, England),
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
[Anti LAV/HTLV III antibodies in blood donors: preliminary results of pool screening of 5 samples].
June 1986, Revue francaise de transfusion et immuno-hematologie,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
[Anti-HTLV-III/LAV antibodies in hematology reactives].
January 1986, Sangre,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
Anti-LAV/HTLV-III antibodies in high and low risk groups.
January 1987, Antibiotics and chemotherapy,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
Anti-LAV/HTLV-III antibodies in groups of individuals at high risk for infection in Italy.
January 1985, La Ricerca in clinica e in laboratorio,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
[Laboratory results in the evaluation of anti HTLV-III in subjects at risk].
January 1985, Rivista di emoterapia ed immunoematologia,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
[False-positive results in the detection of anti-LAV/HTLV-III antibodies by enzyme immunoassay].
June 1986, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
LAV/HTLV-III and sperm antibodies.
December 1986, Fertility and sterility,
G Bedarida, and F D'Agostino, and M G Ronsivalle, and E Berto, and G Cambiè, and N Berto, and M E Grisi, and I Arcidiacono, and G Sterza
[Anti-LAV/HTLV III antibodies in wives of seropositive hemophilic patients].
October 1986, Presse medicale (Paris, France : 1983),
Copied contents to your clipboard!